Daly/Cost comparison in the management of peripheral arterial disease at 17 Belgian hospitals
- PMID: 38243251
- PMCID: PMC10797854
- DOI: 10.1186/s12913-023-10535-2
Daly/Cost comparison in the management of peripheral arterial disease at 17 Belgian hospitals
Abstract
Objective: Peripheral arterial disease (PAD) is a manifestation of atherosclerosis that affects the lower extremities and afflicts more than 200 million people worldwide. Because of limited resources, the need to provide quality care associated with cost control is essential for health policies. Our study concerns an interhospital comparison among seventeen Belgian hospitals that integrates the weighting of quality indicators and the costs of care, from the hospital perspective, for a patient with this pathology in 2018.
Methods: The disability-adjusted life years (DALYs) were calculated by adding the number of years of life lost due to premature death and the number of years of life lost due to disability for each in-hospital stay. The DALY impact was interpreted according to patient safety indicators. We compared the hospitals using the adjusted values of costs and DALYs for their case mix index, obtained by relating the observed value to the predicted value obtained by linear regression.
Results: We studied 2,437 patients and recorded a total of 560.1 DALYs in hospitals. The in-hospital cost average [standard deviation (SD)] was €8,673 (€10,893). Our model identified the hospitals whose observed values were higher than predicted; six needed to reduce the costs and impacts of DALYs, six needed to improve one of the two factors, and four seemed to have good results. The average cost (SD) for the worst performing hospitals amounted to €27,803 (€28,358).
Conclusions: Studying the costs of treatment according to patient safety indicators permits us to evaluate the entire chain of care using a comparable unit of measurement.
Keywords: Atherosclerosis; Complication; Cost; DALY; Disability-Adjusted Life Year; Peripheral arterial disease.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures

Similar articles
-
Cost-DALY comparison of hip replacement care in 12 Belgian hospitals.BMJ Open Qual. 2021 Sep;10(3):e001263. doi: 10.1136/bmjoq-2020-001263. BMJ Open Qual. 2021. PMID: 34580082 Free PMC article.
-
[Evaluation of the burden of diabetes in Poland].Pol Arch Med Wewn. 2001 Sep;106(3):867-73. Pol Arch Med Wewn. 2001. PMID: 11928598 Polish.
-
The health and economic burden of haemophilia in Belgium: a rare, expensive and challenging disease.Orphanet J Rare Dis. 2014 Mar 21;9:39. doi: 10.1186/1750-1172-9-39. Orphanet J Rare Dis. 2014. PMID: 24655371 Free PMC article.
-
Breastfeeding promotion and priority setting in health.Health Policy Plan. 1996 Jun;11(2):156-68. doi: 10.1093/heapol/11.2.156. Health Policy Plan. 1996. PMID: 10158457 Review.
-
Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010.Glob Heart. 2014 Mar;9(1):145-158.e21. doi: 10.1016/j.gheart.2013.12.008. Glob Heart. 2014. PMID: 25432124 Review.
References
-
- WHO Study Group on the Classification of Atherosclerotic Lesions, World Health Organization: Classification of Atherosclerotic Lesions: Report of a Study Group [Met in Washington, October 7–11, 1957]. Technical Report Series; No. 143. Geneva: World Health Organization. 1958 - PubMed
-
- Sampson UK, Fowkes FG, McDermott MM, Criqui MH, Aboyans V, Norman PE, Forouzanfar MH, Naghavi M, Song Y, Harrell FE, Jr, Denenberg JO, Mensah GA, Ezzati M, Murray C. Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010. Glob Heart. 2014;9:145–158.e21. doi: 10.1016/j.gheart.2013.12.008. - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical